About Tel Aviv Sourasky Medical Center Department of Hematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tel Aviv Sourasky Medical Center Department of Hematology
During the past decade, Tel Aviv Sourasky Medical Center Department of Hematology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on
average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
Completed
500
Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
1996-07-01
Unknown status
4,000
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
1997-11-01
Completed
859
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
1999-09-01
2005-12-01
Completed
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
2000-06-01
2002-04-01
Completed
730
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tel Aviv Sourasky Medical Center Department of Hematology"
#1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Tel Aviv Sourasky Medical Center Department of Hematology
According to Clinical.Site data, the most researched conditions in "Tel Aviv Sourasky Medical Center Department of Hematology" are
"Multiple Myeloma" (3 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Tel Aviv Sourasky Medical Center Department of Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Tel Aviv Sourasky Medical Center Department of Hematology
Most popular intervention types in "Tel Aviv Sourasky Medical Center Department of Hematology" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Chlorambucil" (2 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials) and "GED-0301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tel Aviv Sourasky Medical Center Department of Hematology
The vast majority of trials in "Tel Aviv Sourasky Medical Center Department of Hematology" are
15 trials for "All" genders.
Clinical Trials Status at Tel Aviv Sourasky Medical Center Department of Hematology
Currently, there are NaN active trials in "Tel Aviv Sourasky Medical Center Department of Hematology".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Tel Aviv Sourasky Medical Center Department of Hematology,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Tel Aviv Sourasky Medical Center Department of Hematology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".